SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

SPY is rallying in after-hours trading following reports that the U.S. is prepared to conclude military operations against Iran even if the Strait of Hormuz remains closed. While the news sparked an immediate surge in equity futures and a cooling in oil prices, the community remains deeply divided, with many traders debating whether this is a genuine de-escalation or a tactical 'pump and dump' setup ahead of potential further conflict.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing significant downward pressure as investors weigh potential memory sector headwinds, including AI efficiency developments, alongside broader market anxiety surrounding geopolitical tensions. The community is actively debating whether this pullback represents a fundamental shift in the cyclical demand for memory chips or a tactical entry point for long-term investors following recent earnings strength.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending as investors debate the impact of potential regulatory delays and upcoming token unlocks on the asset's price, while community members remain divided between long-term institutional adoption narratives and short-term volatility concerns. The conversation is dominated by contrasting perspectives on Ripple's strategic direction and the timing of the U.S. Clarity Act, with many active traders closely monitoring macro factors and institutional sentiment.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is currently a focal point for investors as they navigate high volatility and institutional positioning ahead of upcoming Medicare Advantage rate announcements. The community is sharply divided, with some betting on a major bounce and institutional accumulation while others remain skeptical due to ongoing regulatory scrutiny and persistent macroeconomic headwinds.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as shareholders weigh a cryptic message from CEO Dr. Patrick Soon-Shiong about "strengthening the balance sheet" and "recharging for global expansion," which has sparked intense debate over whether it signals non-dilutive funding or future share dilution. The community is actively discussing the potential for international partnerships, particularly in the Middle East and Europe, while expressing frustration over ongoing short-seller activity and legal challenges.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space is trending due to heightened community speculation surrounding a potential SpaceX IPO and the company's recent operational updates, including a strategic partnership with Mu-G Technologies for microgravity missions. While bulls highlight the stock's low float and potential for a short squeeze alongside broader space sector growth, bears remain skeptical, citing leadership turnover and a lack of revenue as significant red flags.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and intense social media debate, driven by skepticism over its ongoing Bitcoin treasury strategy and concerns about the dilutive impact of capital raises. While some traders continue to capitalize on the stock's high-beta sensitivity to Bitcoin price action, others are actively betting against the company, citing long-term sustainability risks and the aggressive issuance of equity and debt.

Invesco QQQ Trust Series 1 - Units of beneficial interest

Market participants are reacting to conflicting signals regarding the conflict in Iran, with sentiment being driven by speculative headlines about potential de-escalation versus fears of a prolonged energy crisis. The community is actively debating the reliability of these news sources, with many expressing skepticism about the sustainability of overnight rallies and remain focused on how geopolitical tensions and oil price volatility will impact broader equity trends.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is capturing significant market attention as a unique, permissionless brand driven by an unusually active community that focuses on real-world utility and product development rather than standard crypto hype. Enthusiasts are actively rallying behind its various grassroots initiatives, including apparel, food products, and lifestyle events, which they argue distinguishes the project from typical short-term speculative assets.

BlackRock, Inc. engages in the provision of investment, advisory, and risk management solutions. Its products include single-asset and multi-asset portfolios. The company was founded by Laurence Douglas Fink and Robert Steven Kapito in 1988 and is headquartered in New York, NY.

Blackrock Inc.

BlackRock is trending following the landmark achievement of surpassing $14 trillion in total assets under management, a milestone that has sparked widespread debate about the firm's expanding influence on global markets and potential regulatory scrutiny. Community sentiment remains split, with some investors focusing on the stock's long-term growth potential and strategic pivot into private credit and digital assets, while others voice concerns over the systemic risks posed by such extreme institutional concentration.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CareDx (NASDAQ:CDNA) Share Price Crosses Below Two Hundred Day Moving Average - Time to Sell?

CareDx (NASDAQ:CDNA) Shares Cross Below 200-Day Moving Average - Time to Sell...

Fred Alger Management LLC Sells 304,736 Shares of CareDx, Inc. $CDNA

Fred Alger Management LLC trimmed its position in CareDx, Inc. (NASDAQ:CDNA - Free Report) by 24.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities...

Bamco Inc. NY Has $45.88 Million Stake in CareDx, Inc. $CDNA

Bamco Inc. NY grew its stake in shares of CareDx, Inc. (NASDAQ:CDNA - Free Report) by 29.5% during the third quarter, according to the company in its most recent disclosure with the Securities and...

Braidwell LP Makes New Investment in CareDx, Inc. $CDNA

Braidwell LP purchased a new position in CareDx, Inc. (NASDAQ:CDNA - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange...

CareDx, Inc. $CDNA Shares Purchased by ArrowMark Colorado Holdings LLC

ArrowMark Colorado Holdings LLC raised its stake in shares of CareDx, Inc. (NASDAQ:CDNA - Free Report) by 34.4% during the third quarter, according to its most recent filing with the Securities and...

Portolan Capital Management LLC Grows Stake in CareDx, Inc. $CDNA

Portolan Capital Management LLC raised its stake in shares of CareDx, Inc. (NASDAQ:CDNA - Free Report) by 48.2% in the third quarter, according to the company in its most recent 13F filing with the...

CareDx Introduces VANTx AI Platform for Complex Transplant Datasets

CDNA launches VANTx, an AI-driven cloud platform that turns complex transplant datasets into insights to support clinical research and real-world evidence.

CareDx Details Transplant+ Roadmap, AlloHeme Timeline, and 2026 Outlook at Raymond James Conference

CareDx (NASDAQ:CDNA) executives outlined the company's transplant-focused strategy, recent financial performance, and 2026 priorities during remarks at the Raymond James Institutional Investor...

CareDx, Inc. (NASDAQ:CDNA) Given Consensus Rating of "Hold" by Analysts

CareDx, Inc. (NASDAQ:CDNA - Get Free Report) has received an average recommendation of "Hold" from the nine research firms that are covering the firm, MarketBeat.com reports. One investment analyst...

CareDx Announces VANTx, an AIPowered Clinical Data & Analytics Platform Built on CareDxs Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets

CareDx, Inc. (Nasdaq: CDNA) The Transplant Company, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, highvalue...

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Caredx Inc

Patrick OShaughnessy - @patrick_oshag on X

Citrini - @Citrini7 on X

Bucco Capital - @buccocapital on X

Joe Weisenthal - @TheStalwart on X

The must-watch individual or show that brings entertainment to finance. This award celebrates the content you look forward to daily - bringing a sharp market edge to engaging discussions. 

Current Price	$16.43
Prev Close	$16.78
Open	$16.80
Dividend Yield	0.00%
50-Day Moving Average	$18.89
Beta	1.52
Avg. Volume	704,196.21
PE Ratio	-41.67

52-Week High	$21.49
52-Week Low	$10.96
Market Capitalization	$859.41M
EPS (Annual)	-$0.4007
Price to Book	2.76
Revenue Per Employee	$496,477.12

CDNA
Caredx Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CDNA News

CDNACaredx Inc